Servier Pharmaceuticals LLC was awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The $13,821.79 firm fixed price order is for one unit of 750U PegasparGase, also known as Oncaspar, to be delivered to a location in San Diego, California by December 2, 2021. The delivery order was issued on November 4, 2021 under Master GSA Schedule FSS-61-IB, which...
Servier Pharmaceuticals LLC was awarded a $29,816.13 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The order is for the pharmaceutical product ONCASPAR and has a period of performance through November 30, 2020. No set-aside designation was applied to this award. Servier Pharmaceuticals LLC will deliver the ordered products to the place of...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Sterisyn Inc., a self-certified small disadvantaged business, for the purchase of various pharmaceutical products. The $189,057.96 firm fixed price contract was awarded on October 5, 2020 under the VA's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs, with a potential value of $360,000 through April 2024. Under this indefinite delivery vehicle, Sterisyn Inc....
This is a federal contract award made by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency, to Eisai Inc., a foreign-owned, for-profit manufacturer of goods. The contract has an Award ID of V797P2106D|VA26217F0714 and is for Medical Equipment and Supplies (MEDS). It is a Delivery Order placed against the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, with a Firm Fixed Price pricing type. The contract has a ceiling value of $210,585.58 and an...
This firm fixed price BPA call contract, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VHA VISN 20), is for $31,069.07 in third-party first fill pharmacy services. Set aside for Service-Disabled Veteran-Owned Small Businesses, the contract requires the prime contractor Palisade-Heritage JV LLC to provide prescription drug fulfillment and delivery through May 31, 2023 at locations in Seattle, Washington. As a joint venture,...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency, to Procare Pharmacy Direct, L.L.C. (doing business as CVS Caremark) on August 20, 2024. The contract, titled "FILSPARI", has an ultimate completion date of September 30, 2024 and a ceiling value of $11,280.64. The contract is not associated with a set-aside. Without additional details on the original solicitation, the specific products or services being...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule provides 14,785.51 dollars' worth of peglicatase injection vials for the Richmond Veterans Affairs Medical Center. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded the firm fixed price contract to Horizon Therapeutics USA Inc. on March 24, 2021, with a completion date of February 1, 2022. No set-aside designation was used. The contract utilizes Master...
The Department of Veterans Affairs Veterans Health Administration awarded a $11,283.90 delivery order against Travere Therapeutics, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) to provide FILSPARI 200 MG. As part of VHA's mission to provide healthcare services to veterans, this contract will supply the drug from Travere Therapeutics' Bartlett, Tennessee division to VHA's Veterans Integrated Service Network 5 facilities. With a period of performance from December 13-19,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Incyte Corporation a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets. The order was awarded on May 2, 2023 with a completion date of June 2, 2023 and utilizes firm fixed pricing. Performance will take place in Talleyville, Delaware. No set-aside designation was applied to this order to...
The Department of Veterans Affairs Veterans Health Administration awarded a $11,882.10 delivery order against Genzyme Corporation Sanofi Genzyme Division's Pharmaceuticals and Drugs GSA Schedule contract. Under this firm fixed price order, Genzyme will provide CAPRELSA 100MG to support VHA programs. Performance will take place in Cambridge, Massachusetts over a two week period in November and December 2023. The award utilizes Genzyme's GSA Pharmaceuticals and Drugs Schedule, a multiple award...